A judge has granted Bega’s request to halt US arbitration proceedings between the Australian food maker and Kraft over peanut butter trade dress rights until a related case in Federal Court is resolved.
AMP’s chief executive Craig Meller has resigned after this week’s shocking revelations that the company misled ASIC over fees charged to customers and may have influenced a Clayton Utz report to the securities regulator.
Calling on the competition chief to “have another look” at AGL’s decision to shutter its Liddell plant, Liberal MP Craig Kelly says the power company’s conduct makes for a clear case under the new misuse of market power provision of Australia’s competition law.
A Federal Court judge has criticised the lack of progress in a major class action brought against Ford Australia, telling the applicant’s barrister to “get his act together”.
A lawyer for the University of Sydney has attacked ObjectiVision for failing to produce any commercial benefits from the glaucoma detection method at the centre of a patent infringement dispute, despite holding exclusive rights to the technology for 11 years.
A judge has signed off on a $19.25 million settlement in a shareholder class action brought against directors of defunct laser technology company Arasor International Ltd and partners in auditing firm Grant Thornton South Australia, but cut the legal fees of Squire Patton Boggs and Piper Alderman by $250,000.
Expert witnesses were pitted against each other Wednesday at a trial alleging generic makers infringed a patent covering the anti-depressant Lexapro, and Apotex’ consultant took the brunt of it.
The corporate regulator has confirmed it is investigating AMP over its ‘fees for no service’ practice revealed at the Hayne Royal Commission in stunning testimony Treasurer Scott Morrison on Wednesday called “deeply disturbing”.
A judge has dismissed a bid by Geneva Laboratories to add the sole director of a healthcare product distributor as a defendant in a high-stakes case over counterfeit versions of its popular and premium-priced Bio-Oil line of skin-care products.
Two high ranking analysts from S&P Global have distanced themselves from the decision making process at the heart of a class action over toxic financial products given healthy ratings by the agency ahead of the global financial crisis.